Upon completion of this activity, the participants should be able to:
-
Utilize the diagnosis and management strategies for advanced-stage de novo lung cancer with combined histology
-
Recognize the role of biomarker testing in guiding treatment for patients with advanced-stage lung cancer
-
Review the importance of a multidisciplinary approach and the role of palliative care in managing advanced-stage lung cancer